Kingsview Wealth Management »

Xortx Therapeutics shares owned by Kingsview Wealth Management

Quarter-by-quarter ownership of Xortx Therapeutics shares owned by Kingsview Wealth Management from 13F filings

Historical chart of Kingsview Wealth Management investment in Xortx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xortx Therapeutics held by Kingsview Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xortx Therapeutics by Kingsview Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.1k 15k 0.41

More positions owned by Kingsview Wealth Management

Northern Lts Fd Tr Iv Monarch Procap I (MPRO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Northern Lts Fd Tr Iv Monarch Ambassad (MAMB)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr Series Trust State Street Spd (SPYG)
Northern Lts Fd Tr Iv Monarch Vol Fact (MVFG)
Northern Lts Fd Tr Iv Monarch Blue Ch (MBCC)
Northern Lts Fd Tr Iv Monarch Sel Subs (MSSS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (SPTI)
Northern Lts Fd Tr Iv Monarch Vol Fact (MVFD)
Broadcom (AVGO)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)

View all positions for Kingsview Wealth Management

Top funds holding Xortx Therapeutics

Kingsview Wealth Management
Hartland & Co

View all funds holding Xortx Therapeutics